The dataset ranks 47 companies, with the leading assignee holding 16 of the 169 records in scope and the top five together accounting for 62 records, or 36.7% of the field. Beyond fifth place the numbers taper gradually rather than dropping off a cliff, with tenth place still holding 4 records, so the field has several companies with comparable-sized estates rather than a single dominant gatekeeper. Recent-year momentum data shows some early leaders have dropped to zero filings in the latest year, which is worth checking before assuming their position is still active.

Nucleic acid reduction is one of the defining downstream steps in this dataset’s search scope, sitting alongside heat treatment and drying method as a core processing claim area. The IPC composition shows C12P (fermentation & enzymatic synthesis) covering 21.9% of the 169 records and C12R (microorganism index) at 18.3%, both of which frequently intersect with nucleic-acid-reduction claims. Because this is a heavily processed area of the value chain, new filings here need to check closely against the top-cited records, several of which relate directly to producing food-grade fungal biomass at scale.

Filing activity rose substantially through the early 2020s, from 9 records in 2021 to 21 in 2024, a +133% increase, with a peak of 46 records in 2023. That is a genuine rise in filing pressure, not noise. The 2025 and 2026 figures in any trend chart will look lower simply because publication typically lags filing by around 18 months, so those most recent years should not be read as the field cooling off — they are still filling in.